₹ 308.75
5.00 (1.65%)
M
Marksans Pharma
₹ 308.75
Marksans Pharma Share Price Today
Marksans Pharma (MARKSANS) share price is trading at ₹308.75 on the NSE as of November 9, 2026 at 03:59 PM, up by 1.65% from its previous close of ₹303.75. In todays trading session MARKSANS reached a high of 313.50 and low of 305.20. The average traded price for today is 309.22. The 50 DMA stands at 318.81 and 200 DMA is at 244.57. Looking at intraday trend, the stock is in Uptrend.
Stock Overview
- Symbol : MARKSANS
- Open : ₹305.60
- Previous Close : ₹303.75
- Day's Range : ₹305.20 – ₹313.50
- 52-Week Range : ₹155.00 – ₹350.95
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
MARKSANS Stock Performance
Markets Today
High
313.50
Low
305.20
Open at
305.60
Prev Close
303.75
Volumes
8,23,630
Avg Price
309.22
Lower Circuit
247.00
Upper Circuit
370.50
Last Traded Details
Quantity
119
Time
15:59:38
Price Movement
Historical Performance
3 M High
350.95
3 M Low
268.30
1 Yr High
350.95
1 Yr Low
155.00
3 Yr High
358.70
3 Yr Low
113.75
5 Yr High
358.70
5 Yr Low
38.60
1-Year Performance
MARKSANS Pros and Cons
Operating revenue grew from ₹720 Cr to ₹940 Cr over five quarters, reaching a new high in Q2 FY27
Free cash flow surged from ₹152 Cr to ₹275 Cr in Q2 FY27, highlighting improved capital efficiency
Cash balance rose from ₹666 Cr to ₹1,124 Cr over five quarters, signaling strong liquidity accumulation
Working capital cycle shortened from 150 days to 128 days over five quarters, indicating better operational efficiency
US & North America revenue spiked from ₹377 Cr to ₹761 Cr in Q2 FY27, driving top-line growth
UK & Europe revenue fell from ₹356 Cr to ₹188 Cr in Q2 FY27, indicating regional instability
Net income margin eased from 18.4% to 15.0% in Q2 FY27, reflecting some cost pressures despite revenue growth
MARKSANS Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 1 analysts
Buy
100%
Hold
0%
Sell
0%
Get forecast for Price, ROA & ROE based on analyst ratings.
MARKSANS Share Price History
MARKSANS Fundamentals
Company Valuation
Market Cap (₹ Cr.)
13,995
PE Ratio
24.40
PB Ratio
4.14
Dividend Yield
0.30%
ROE
13.76%
ROCE
17.54%
Book Value (₹)
73.53
Face Value (₹)
1.00
Analyse MARKSANS with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 43.87% | 43.87% | 43.87% | 43.87% | 43.87% |
| Domestic Institutional Investors (DII) | 5.28% | 5.91% | 6.57% | 6.19% | 5.54% |
| Foreign Institutional Investors (FII) | 16.92% | 8.12% | 16.76% | 17.47% | 19.06% |
| Public Investors | 29.53% | 28.98% | 28.33% | 28.05% | 27.05% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Marksans Pharma Return Calculator
Note: Past profits do not guarantee future returns.
MARKSANS Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
MARKSANS Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for MARKSANS
Margin on MARKSANS
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
MARKSANS Financials Summary
In Crores
MARKSANS Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check MARKSANS latest Company Filings, Investor Presentation & Conference Call details.
MARKSANS Revenue Growth
All values are in Crores
Revenue
Profit
Loss
MARKSANS Similar Stocks
FAQs on MARKSANS
What is the share price of Marksans Pharma?
What is the 52W high and 52W low of Marksans Pharma?
What is the return on Marksans Pharma share?
- Past 1 year: 68.76%
- Past 3 years: 165.48%
- Past 5 years: 366.04%
What is the PE and PB Ratio of Marksans Pharma?
What is the EPS of Marksans Pharma?
What is the shareholding pattern of Marksans Pharma?
- DIIs - 5.54%
- FII - 19.06%
- Promoters - 43.87%
- Public Investors 27.05%
- Goverenment - 0.00%
How to buy Marksans Pharma shares online?
How to buy Marksans Pharma shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Marksans Pharma share
- Tap on “Buy”
